Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

AbSci
101 E. 6th Street, Suite 300
Vancouver, WA 98660
Phone: 360-949-1041
http://www.absci.us/

AbSci is a global leader in cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry. The company\'s SoluPro™ expression platform achieves revolutionary yields of soluble and active protein product across a diverse range of targets. AbSci\'s unique approach accelerates drug discovery timelines, increases manufacturing efficiencies, and drastically reduces costs for the biopharmaceutical industry.

Key Contact
Name
Sean McClain
Title
CEO
Funding Events

Date
Amount
Type
Investors
04/25/16 $5,100,000 Series A Phoenix Venture Partners
05/30/18 $12,000,000 Series C Asahi Glass
Columbia Ventures
Greenbridge Investment Partners
Oregon Venture Fund
Phoenix Venture Partners
Souther Co.
WRF Capital
02/22/21 undisclosed Strategic Merck Global Health Innovation Fund